Table 4.
Paired analysis comparing HPV detection among any tissue from a case (lesion or perilesion) versus any tissue from a control (sun-exposed or sun-protected skin)
Combined case sites (n=72) no. (%) | Combined control sites (n=95) no. (%) | OR (95% CI) | |
---|---|---|---|
Any HPV | 52 (72%) | 71 (75%) | 0.8 (0.3–1.8) |
| |||
α-Papillomavirus | 11 (15%) | 6 (6%) | 2.8 (0.8–9.8) |
9 | 4 (6%) | 0 (0%) | ∞ |
10 | 7 (10%) | 3 (3%) | 2.3 (0.4–12.0) |
| |||
β-Papillomavirus | 47 (65%) | 68 (72%) | 0.7 (0.3–1.6) |
1 | 36 (50%) | 39 (41%) | 1.7 (0.8–3.5) |
2 | 28 (39%) | 43 (45%) | 0.8 (0.4–1.6) |
3 | 3 (4%) | 10 (11%) | 1.2 (0.3–4.9) |
| |||
γ-Papillomavirus | 10 (14%) | 9 (9%) | 1.3 (0.5–4.0) |
3 | 7 (10%) | 4 (4%) | 2.5 (0.6–10.3) |
CI, confidence interval; HPV, human papillomavirus; OR, odds ratio.